Kambiz Yazdi
Stock Analyst at Jefferies
(2.98)
# 1,553
Out of 5,014 analysts
7
Total ratings
71.43%
Success rate
44.76%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Kambiz Yazdi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AVTX Avalo Therapeutics | Initiates: Buy | $23 | $14.02 | +64.05% | 1 | Mar 25, 2025 | |
| ARQT Arcutis Biotherapeutics | Maintains: Buy | $16 → $19 | $19.90 | -4.52% | 2 | Mar 11, 2025 | |
| EYPT EyePoint Pharmaceuticals | Initiates: Buy | $15 | $13.72 | +9.33% | 1 | Aug 28, 2024 | |
| PMVP PMV Pharmaceuticals | Initiates: Buy | $5 | $1.33 | +275.94% | 1 | Apr 12, 2024 | |
| PRAX Praxis Precision Medicines | Maintains: Buy | $75 → $128 | $52.90 | +141.97% | 2 | Mar 26, 2024 |
Avalo Therapeutics
Mar 25, 2025
Initiates: Buy
Price Target: $23
Current: $14.02
Upside: +64.05%
Arcutis Biotherapeutics
Mar 11, 2025
Maintains: Buy
Price Target: $16 → $19
Current: $19.90
Upside: -4.52%
EyePoint Pharmaceuticals
Aug 28, 2024
Initiates: Buy
Price Target: $15
Current: $13.72
Upside: +9.33%
PMV Pharmaceuticals
Apr 12, 2024
Initiates: Buy
Price Target: $5
Current: $1.33
Upside: +275.94%
Praxis Precision Medicines
Mar 26, 2024
Maintains: Buy
Price Target: $75 → $128
Current: $52.90
Upside: +141.97%